Market Trends
Covidien Executive: Two Datapoints that Device Firms Need to Pay Close Attention To
May 09, 2013
Stacy Enxing Seng, President of Vascular Therapies, Covidien The IBF MedTech Investing Conference, which takes place in Minneapolis annually, has been...
The Medtech Q1 Round Up: Among Big Device Firms, Earnings Are Painful Across the Board
Apr 26, 2013
The first quarter results are still trickling in, but for the most part, firms among the top influencers seem to be reflecting a continued difficult climate in...
Wake Up and Smell the Coffee. Do Outcomes Research Or Die.
Apr 12, 2013
The writing is on the wall. If device firms are not focusing on outcomes research, they will lose big time in the future. Here's one more reason for it. The...
Medtronic Executive Describes Eye-Opening Experiences in Global Markets
Apr 08, 2013
Medtronic, like many other medical device firms, is looking at what the right mix of strategies is when trying to penetrate global markets. The experience has...
The Current and Future State of Medtech in India
Apr 04, 2013
Brazil, Russia, India, and China, collectively known as the BRIC countries, are the largest players in the medical device arena, following the United States,...
Global Injectable Drug Delivery Technology Market to Grow to $43.3 billion in 2017
Apr 01, 2013
Last week, Becton Dickinson said that the FDA had approved its antihistamine drug in prefilled syringes. The company also plans to introduce 20 to 30 other...
Medical Device Tax in Jeopardy After Senate Votes to Repeal
Mar 22, 2013
Late Thursday night the Senate voted to an overwhelming 79-20 tally to repeal the medical device tax.The vote included 33 Democrats who voted alongside...
Beware the Fog of Outsourcing
Mar 12, 2013
A report released by analyst and strategic advisory firm Axendia cautions device companies to look before they leap when it comes to outsourcing. The...
Going it Alone is a Poor Strategy in Trying to Break into Emerging Markets
Mar 06, 2013
 As growth slows in mature markets like the U.S., Europe and Japan, medical technology companies are looking toward emerging markets as the messiah. After...
Going it Alone is a Poor Strategy in Trying to Break into Emerging Markets
Mar 06, 2013
 As growth slows in mature markets like the U.S., Europe and Japan, medical technology companies are looking toward emerging markets as the messiah. After...